David C. Hastings, the Chief Financial Officer of Arbutus Biopharma Corp (NASDAQ:ABUS), recently sold 22,183 common shares of ...
Hosted on MSN1d
Why The Arbutus Is A Popular Tree For Warm ClimatesThe Arbutus tree has so many wonderful attributes; it's no surprise this fruiting evergreen is gaining popularity amongst ...
SG Americas Securities LLC grew its stake in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 30.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned ...
2don MSN
Baltimore County Public Schools is proposing to send 21 students exclusively into already overcapacity Catonsville Middle ...
Jan. 13, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology ...
Arbutus Biopharma (NASDAQ:ABUS) was able to report positive data from its phase 2a IM-PROVE I trial, which used its drug Imdusiran [AB-729] together with short courses of pegylated interferon alfa ...
In a display of unity and compassion, community members come together to support 28-year-old Brieanna Raider, a mother of two ...
Arbutus Biopharma Corp (NASDAQ: ABUS )首席财务官David C. Hastings近期出售了22,183股公司普通股。这些股份以平均价格3.283美元售出，交易总额为72,826美元。此次出售后，Hastings仍持有公司159,724股股份。目前该公司股票交易价格为3.59美元，高于交易价格，分析师给出的目标价格区间为3.90美元至7.03美元。根据 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback